Chapter 9: Pediatric tuberculosis

References

• World Health Organization. Guidance for National Tuberculosis Programmes on the Management of Tuberculosis in Children. Geneva: WHO Press; 2006. 41.
   Google Scholar
• Morris SK, Giroux RJP, Consunji-Araneta R, et al. Epidemiology, clinical features and outcomes of incident tuberculosis in children in Canada in 2013-2016: results of a national surveillance study. Arch Dis Child. 2021;106(12):1165–1170. doi:10.1136/archdischild-2021-322092.
   PubMed Web of Science ®Google Scholar
• Statistics Canada. Census in Brief: Diverse family characteristics of Aboriginal children aged 0 to 4. Available at: https://www12.statcan.gc.ca/census-recensement/2016/as-sa/98-200-x/2016020/98-200-x2016020-eng.cfm. Accessed July 28, 2021.
   Google Scholar
• Rayment JH, Guthrie JL, Lam K, et al. Culture-positive Pediatric Tuberculosis in Toronto, Ontario: Sources of Infection and Relationship of Birthplace and Mycobacterial Lineage to Phenotype. Pediatr Infect Dis J. 2016;35(1):13–18. doi:10.1097/INF.0000000000000915.
   PubMed Web of Science ®Google Scholar
• Perez-Velez CM, Marais BJ. Tuberculosis in children. N Engl J Med. 2012;367(4):348–361. doi:10.1056/NEJMra1008049.
   PubMed Web of Science ®Google Scholar
• Marais BJ, Gie RP, Schaaf HS, et al. The natural history of childhood intra-thoracic tuberculosis: a critical review of literature from the pre-chemotherapy era. Int J Tuberc Lung Dis. 2004;8(4):392–402.
   PubMed Web of Science ®Google Scholar
• Crockett M, King SM, Kitai I, Outbreak Investigation Team, et al. Nosocomial transmission of congenital tuberculosis in a neonatal intensive care unit. Clin Infect Dis. 2004;39(11):1719–1723. doi:10.1086/425740.
   PubMed Web of Science ®Google Scholar
• Cruz AT, Starke JR. A current review of infection control for childhood tuberculosis. Tuberculosis (Edinb). 2011;91 Suppl 1 (Suppl 1):S11–S5. doi:10.1016/j.tube.2011.10.004.
   PubMedGoogle Scholar
• Marais BJ, Gie RP, Schaaf HS, et al. The clinical epidemiology of childhood pulmonary tuberculosis: A critical review of literature from the pre-chemotherapy era. International Journal of Tuberculosis and Lung Disease. 2004;8(3):278–285.
   PubMed Web of Science ®Google Scholar
• Phongsamart W, Kitai I, Gardam M, et al. A population-based study of tuberculosis in children and adolescents in Ontario. Pediatr Infect Dis J. 2009;28(5):416–419. doi:10.1097/INF.0b013e3181920d4d.
   PubMed Web of Science ®Google Scholar
• Vonasek B, Ness T, Takwoingi Y, et al. Screening tests for active pulmonary tuberculosis in children. Cochrane Database Syst Rev. 2021;6:CD013693 doi:10.1002/14651858.CD013693.pub2.
   PubMedGoogle Scholar
• Schaaf HS, Collins A, Bekker A, Davies PD. Tuberculosis at extremes of age. Respirology. 2010;15(5):747–763. doi:10.1111/j.1440-1843.2010.01784.x.
   PubMed Web of Science ®Google Scholar
• Whittaker E, Kampmann B. Perinatal tuberculosis: new challenges in the diagnosis and treatment of tuberculosis in infants and the newborn. Early Hum Dev. 2008;84(12):795–799. doi:10.1016/j.earlhumdev.2008.09.005.
   PubMed Web of Science ®Google Scholar
• Dheda K, Makambwa E, Esmail A. The Great Masquerader: Tuberculosis Presenting as Community-Acquired Pneumonia. Semin Respir Crit Care Med. 2020;41(4):592–604. doi:10.1055/s-0040-1710583.
   PubMedGoogle Scholar
• Graham SM, Cuevas LE, Jean-Philippe P, et al. Clinical Case Definitions for Classification of Intrathoracic Tuberculosis in Children: An Update. Clin Infect Dis. 2015;61 (Suppl 3):S179–S87. doi:10.1093/cid/civ581.
   Web of Science ®Google Scholar
• Snow KJ, Cruz AT, Seddon JA, et al. Adolescent tuberculosis. Lancet Child Adolesc Health. 2020;4(1):68–79. doi:10.1016/S2352-4642(19)30337-2.
   PubMedGoogle Scholar
• Nemir RL, Krasinski K. Tuberculosis in children and adolescents in the 1980s. Pediatr Infect Dis J. 1988;7(6):375–379. doi:10.1097/00006454-198806000-00001.
   PubMed Web of Science ®Google Scholar
• Cruz AT, Hwang KM, Birnbaum GD, Starke JR. Adolescents with tuberculosis: a review of 145 cases. Pediatr Infect Dis J. 2013;32(9):937–941. doi:10.1097/INF.0b013e3182933214.
   PubMed Web of Science ®Google Scholar
• Kam A, Ford-Jones L, Malloy P, et al. Active tuberculosis among adolescents in toronto, Canada: clinical features and delays in diagnosis. Pediatr Infect Dis J. 2007;26(4):355–356. doi:10.1097/01.inf.0000258700.86040.b6.
   Web of Science ®Google Scholar
• Xu JJ, Peer S, Papsin BC, et al. Tuberculous lymphadenitis of the head and neck in Canadian children: Experience from a low-burden region. Int J Pediatr Otorhinolaryngol. 2016;91:11–14. doi:10.1016/j.ijporl.2016.09.035.
   PubMed Web of Science ®Google Scholar
• Ioos V, Cordel H, Bonnet M. Alternative sputum collection methods for diagnosis of childhood intrathoracic tuberculosis: a systematic literature review. Arch Dis Child. 2019;104(7):629–635. doi:10.1136/archdischild-2018-315453.
   PubMed Web of Science ®Google Scholar
• Yip D, Bhargava R, Yao Y, et al. Pediatric tuberculosis in Alberta: epidemiology and case characteristics (1990-2004). Can J Public Health. 2007;98(4):276–280. doi:10.1007/BF03405402.
   PubMed Web of Science ®Google Scholar
• American Academy of Pediatrics. Red Book: 2021–2024 Report of the Committee on Infectious Diseases. USA: American Academy of Pediatrics. 2021; 786–814. chap Tuberculosis.
   Google Scholar
• Loeffler AM. Pediatric tuberculosis. Semin Respir Infect. 2003;18(4):272–291. doi:10.1053/S0882-0546(03)00071-9.
   PubMedGoogle Scholar
• Mandalakas AM, Starke JR. Current concepts of childhood tuberculosis. Semin Pediatr Infect Dis. 2005;16(2):93–104. doi:10.1053/j.spid.2005.01.001.
   PubMedGoogle Scholar
• Curry International Tuberculosis Center. Pediatric Tuberculosis: A Guide to the Gastric Aspirate Procedure. Available at: https://www.currytbcenter.ucsf.edu/products/pediatric-tuberculosis-guide-gastric-aspirate-procedure/7-steps-collect-ga/step-4-obtain. Accessed August 8, 2021.
   Google Scholar
• Schaaf HS, Hesseling AC. Induced sputum microbiology in confirming pulmonary tuberculosis in children. Int J Tuberc Lung Dis. 2011;15(9):1139. doi:10.5588/ijtld.11.0474.
   PubMed Web of Science ®Google Scholar
• Abadco DL, Steiner P. Gastric lavage is better than bronchoalveolar lavage for isolation of Mycobacterium tuberculosis in childhood pulmonary tuberculosis. Pediatr Infect Dis J. 1992;11(9):735–738. doi:10.1097/00006454-199209000-00013.
   PubMed Web of Science ®Google Scholar
• Arlaud K, Gorincour G, Bouvenot J, et al. Could CT scan avoid unnecessary flexible bronchoscopy in children with active pulmonary tuberculosis? A retrospective study. Arch Dis Child. 2010;95(2):125–129. doi:10.1136/adc.2009.151639.
   PubMed Web of Science ®Google Scholar
• Wright CA, Hesseling AC, Bamford C, et al. Fine-needle aspiration biopsy: a first-line diagnostic procedure in paediatric tuberculosis suspects with peripheral lymphadenopathy? Int J Tuberc Lung Dis. 2009;13(11):1373–1379.
   PubMed Web of Science ®Google Scholar
• Wright CA, Warren RM, Marais BJ. Fine needle aspiration biopsy: an undervalued diagnostic modality in paediatric mycobacterial disease. Int J Tuberc Lung Dis. 2009;13(12):1467–1475.
   PubMed Web of Science ®Google Scholar
• Fontanilla JM, Barnes A, von Reyn CF. Current diagnosis and management of peripheral tuberculous lymphadenitis. Clin Infect Dis. 2011;53(6):555–562. doi:10.1093/cid/cir454.
   PubMed Web of Science ®Google Scholar
• Rock RB, Olin M, Baker CA, et al. Central nervous system tuberculosis: pathogenesis and clinical aspects. Clin Microbiol Rev. 2008;21(2):243–261. table of contents. doi:10.1128/CMR.00042-07.
   PubMed Web of Science ®Google Scholar
• Starke J, Cruz AT. Tuberculosis. In: Remington J, Klein J, Wilson C, Nizet V, Maldonado Y, eds. Infectious Diseases of the Fetus and Newborn Infant. 7th ed. Amsterdam: W.B. Saunders Company. 2011; 577–600.
   Google Scholar
• Cordova J, Shiloh R, Gilman RH, et al. Evaluation of molecular tools for detection and drug susceptibility testing of Mycobacterium tuberculosis in stool specimens from patients with pulmonary tuberculosis. J Clin Microbiol. 2010;48(5):1820–1826. doi:10.1128/JCM.01161-09.
   PubMed Web of Science ®Google Scholar
• Donald PR, Schaaf HS, Gie RP, et al. Stool microscopy and culture to assist the diagnosis of pulmonary tuberculosis in childhood. J Trop Pediatr. 1996;42(5):311–312. doi:10.1093/tropej/42.5.311.
   PubMed Web of Science ®Google Scholar
• MacLean E, Sulis G, Denkinger CM, et al. Diagnostic Accuracy of Stool Xpert MTB/RIF for Detection of Pulmonary Tuberculosis in Children: a Systematic Review and Meta-analysis. J Clin Microbiol. 2019;57(6):e02057-18. doi:10.1128/JCM.02057-18.
   Web of Science ®Google Scholar
• Mesman AW, Rodriguez C, Ager E, et al. Diagnostic accuracy of molecular detection of Mycobacterium tuberculosis in pediatric stool samples: A systematic review and meta-analysis. Tuberculosis (Edinb). 2019;119:101878. doi:10.1016/j.tube.2019.101878.
   PubMed Web of Science ®Google Scholar
• Kay AW, González Fernández L, Takwoingi Y, et al. Xpert MTB/RIF and Xpert MTB/RIF Ultra assays for active tuberculosis and rifampicin resistance in children. Cochrane Database Syst Rev. 2020;8:CD013359. doi:10.1002/14651858.CD013359.pub2.
   PubMedGoogle Scholar
• Kabir S, Rahman SMM, Ahmed S, et al. Xpert Ultra Assay on Stool to Diagnose Pulmonary Tuberculosis in Children. Clin Infect Dis. 2021;73(2):226–234. 07 15 doi:10.1093/cid/ciaa583.
   PubMed Web of Science ®Google Scholar
• Jain SK, Andronikou S, Goussard P, et al. Advanced imaging tools for childhood tuberculosis: potential applications and research needs. Lancet Infect Dis. 2020;20(11):e289–e297. doi:10.1016/S1473-3099(20)30177-8.
   PubMed Web of Science ®Google Scholar
• George A, Andronikou S, Pillay T, et al. Intrathoracic tuberculous lymphadenopathy in children: a guide to chest radiography. Pediatr Radiol. 2017;47(10):1277–1282. doi:10.1007/s00247-017-3890-1.
   PubMed Web of Science ®Google Scholar
• Smuts NA, Beyers N, Gie RP, et al. Value of the lateral chest radiograph in tuberculosis in children. Pediatr Radiol. 1994;24(7):478–480. doi:10.1007/BF02015003.
   PubMed Web of Science ®Google Scholar
• Swingler GH, Du Toit G, Andronikou S, et al. Diagnostic accuracy of chest radiography in detecting mediastinal lymphadenopathy in suspected pulmonary tuberculosis. Arch Dis Child. 2005;90(11):1153–1156. doi:10.1136/adc.2004.062315.
   PubMed Web of Science ®Google Scholar
• Du Toit G, Swingler G, Iloni K. Observer variation in detecting lymphadenopathy on chest radiography. Int J Tuberc Lung Dis. 2002;6(9):814–817.
   PubMed Web of Science ®Google Scholar
• Semakula-Katende NS, Andronikou S, Lucas S. Digital platform for improving non-radiologists’ and radiologists’ interpretation of chest radiographs for suspected tuberculosis - a method for supporting task-shifting in developing countries. Pediatr Radiol. 2016;46(10):1384–1391. doi:10.1007/s00247-016-3630-y.
   PubMed Web of Science ®Google Scholar
• Harris M, Qi A, Jeagal L, et al. A systematic review of the diagnostic accuracy of artificial intelligence-based computer programs to analyze chest x-rays for pulmonary tuberculosis. PLoS One. 2019;14(9):e0221339. doi:10.1371/journal.pone.0221339.
   PubMed Web of Science ®Google Scholar
• Gómez-Pastrana D, Carceller-Blanchard A. Should pulmonary computed tomography be performed in children with tuberculosis infection without apparent disease? An Pediatr (Barc). 2007;67(6):585–593. doi:10.1157/13113023.
   PubMedGoogle Scholar
• Kakalia S, Chakravarty A, Manson D, et al. Choosing Wisely: Computed Tomography in the Diagnosis of Adolescents With Intrathoracic Tuberculosis. J Pediatric Infect Dis Soc. 2021;10(4):521–524. doi:10.1093/jpids/piaa134.
   PubMed Web of Science ®Google Scholar
• Neu N, Saiman L, San Gabriel P, et al. Diagnosis of pediatric tuberculosis in the modern era. Pediatr Infect Dis J. 1999;18(2):122–126. doi:10.1097/00006454-199902000-00008.
   PubMed Web of Science ®Google Scholar
• Brenner DJ, Hall EJ. Computed tomography-an increasing source of radiation exposure. N Engl J Med. 2007;357(22):2277–2284. doi:10.1056/NEJMra072149.
   PubMed Web of Science ®Google Scholar
• Dawani A, Gupta AK, Jana M. Imaging in Pediatric Extra-Pulmonary Tuberculosis. Indian J Pediatr. 2019;86(5):459–467. doi:10.1007/s12098-019-02858-y.
   PubMed Web of Science ®Google Scholar
• James V, Samuel J, Ong GY. Pediatric Abdominal Tuberculosis With Calcified Intra-abdominal Lymph Nodes Identified by Point-of-Care Ultrasound. Pediatr Emerg Care. 2021;37(4):226–229. doi:10.1097/PEC.0000000000002320.
   PubMed Web of Science ®Google Scholar
• Skoura E, Zumla A, Bomanji J. Imaging in tuberculosis. Int J Infect Dis. 2015;32:87–93. doi:10.1016/j.ijid.2014.12.007.
   PubMed Web of Science ®Google Scholar
• Bomanji JB, Gupta N, Gulati P, Das CJ. Imaging in tuberculosis. Cold Spring Harb Perspect Med. 2015;5(6):a017814–a017814. doi:10.1101/cshperspect.a017814.
   PubMed Web of Science ®Google Scholar
• Trivedi R, Saksena S, Gupta RK. Magnetic resonance imaging in central nervous system tuberculosis. Indian J Radiol Imaging. 2009;19(4):256–265. doi:10.4103/0971-3026.57205.
   PubMedGoogle Scholar
• Chen RY, Dodd LE, Lee M, et al. PET/CT imaging correlates with treatment outcome in patients with multidrug-resistant tuberculosis. Sci Transl Med. 2014;6(265):265ra166 doi:10.1126/scitranslmed.3009501.
   PubMed Web of Science ®Google Scholar
• Kampmann B, Whittaker E, Williams A, et al. Interferon-gamma release assays do not identify more children with active tuberculosis than the tuberculin skin test. Eur Respir J. 2009;33(6):1374–1382. doi:10.1183/09031936.00153408.
   PubMed Web of Science ®Google Scholar
• Nash M, Perrin C, Seddon JA, et al. Access to paediatric formulations for the treatment of childhood tuberculosis. Lancet Child Adolesc Health. 2020;4(12):855–857. doi:10.1016/S2352-4642(20)30273-X.
   PubMedGoogle Scholar
• McIlleron H, Chirehwa MT. Current research toward optimizing dosing of first-line antituberculosis treatment. Expert Rev anti Infect Ther. 2019;17(1):27–38. doi:10.1080/14787210.2019.1555031.
   PubMed Web of Science ®Google Scholar
• Peloquin CA, Durbin D, Childs J, et al. Stability of antituberculosis drugs mixed in food. Clin Infect Dis. 2007;45(4):521 doi:10.1086/520011.
   PubMed Web of Science ®Google Scholar
• Blumberg HM, Burman WJ, Chaisson RE, American Thoracic Society, Centers for Disease Control and Prevention and the Infectious Diseases Society, et al. American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America: treatment of tuberculosis. Am J Respir Crit Care Med. 2003;167(4):603–662. doi:10.1164/rccm.167.4.603.
   PubMed Web of Science ®Google Scholar
• Curry International Tuberculosis Center. Resources: Medication Delivery Tips. Available at: https://www.currytbcenter.ucsf.edu/products/pediatric-tuberculosis-online-presentation/resources. Accessed August 8, 2021.
   Google Scholar
• McIlleron H, Willemse M, Schaaf HS, et al. Pyrazinamide plasma concentrations in young children with tuberculosis. Pediatr Infect Dis J. 2011;30(3):262–265. doi:10.1097/INF.0b013e3181fbefe1.
   Web of Science ®Google Scholar
• SickKids. Compounding Pharmacy Service. Available at: https://www.sickkids.ca/en/care-services/for-health-care-providers/compounding-service/. Accessed August 8, 2021.
   Google Scholar
• Centre Hospitalier Universitaire Sainte-Justine. Guide de Formulations Magistrales. Available at: https://www.chusj.org/fr/soins-services/P/Pharmacie/Outils/Formulations-magistrales. Accessed August 8, 2021.
   Google Scholar
• Curry International Tuberculosis Center and California Dept. of Health. Drug-Resistant Tuberculosis: A Survival Guide for Clinicians. 3rd ed. CA; 2016; 304. Available at: https://www.currytbcenter.ucsf.edu/sites/default/files/tb_sg3_book.pdf. Accessed August 8, 2021.
   Google Scholar
• Schaaf HS. Diagnosis and Management of Multidrug-Resistant Tuberculosis in Children: A Practical Approach. Indian J Pediatr. 2019;86(8):717–724. doi:10.1007/s12098-018-02846-8.
   PubMed Web of Science ®Google Scholar
• Osman M, Harausz EP, Garcia-Prats AJ, for The Collaborative Group for Meta-Analysis of Paediatric Individual Patient Data in MDR TB, et al. Treatment Outcomes in Global Systematic Review and Patient Meta-Analysis of Children with Extensively Drug-Resistant Tuberculosis. Emerg Infect Dis. 2019;25(3):441–450. doi:10.3201/eid2503.180852.
   PubMed Web of Science ®Google Scholar
• Harausz EP, Garcia-Prats AJ, Law S, for the Collaborative Group for Meta-Analysis of Paediatric Individual Patient Data in MDR-TB, et al. Treatment and outcomes in children with multidrug-resistant tuberculosis: A systematic review and individual patient data meta-analysis. PLoS Med. 2018;15(7):e1002591. doi:10.1371/journal.pmed.1002591.
   PubMed Web of Science ®Google Scholar
• Lewinsohn DM, Leonard MK, LoBue PA, et al. Official American Thoracic Society/Infectious Diseases Society of America/Centers for Disease Control and Prevention Clinical Practice Guidelines: Diagnosis of Tuberculosis in Adults and Children. Clin Infect Dis. 2017;64(2):111–115. doi:10.1093/cid/ciw778.
   PubMedGoogle Scholar
• Wobudeya E, Chabala C, Hesseling A. Shorter treatment for minimal tuberculosis in children: main findings from the SHINE trial. 2020. 407–408.
   Google Scholar
• World Health Organization. Rapid Advice: treatment of Tuberculosis in Children. Geneva: WHO Press; 2010; 19. Available at: http://apps.who.int/iris/handle/10665/44444.
   Google Scholar
• Ridge A, Whyte P, Grzemska M, et al. Beyond randomized trials-TB treatment in children. Evid-Based Child Health. 2010;5(4):1566–1577. doi:10.1002/ebch.589.
   Google Scholar
• Menon PR, Lodha R, Sivanandan S, Kabra SK. Intermittent or daily short course chemotherapy for tuberculosis in children: meta-analysis of randomized controlled trials. Indian Pediatr. 2010;47(1):67–73. doi:10.1007/s13312-010-0009-2.
   PubMed Web of Science ®Google Scholar
• Te Water Naude JM, Donald PR, Hussey GD, et al. Twice weekly vs. daily chemotherapy for childhood tuberculosis. Pediatr Infect Dis J. 2000;19(5):405–410. doi:10.1097/00006454-200005000-00004.
   PubMed Web of Science ®Google Scholar
• Varudkar BL. Short course chemotherapy for tuberculosis in children. Indian J Pediatr. 1985;52(419):593–597. doi:10.1007/BF02749562.
   PubMedGoogle Scholar
• Thwaites G, Fisher M, Hemingway C, et al. British Infection Society guidelines for the diagnosis and treatment of tuberculosis of the central nervous system in adults and children. J Infect. 2009;59(3):167–187. doi:10.1016/j.jinf.2009.06.011.
   PubMed Web of Science ®Google Scholar
• Prasad K, Singh MB, Ryan H. Corticosteroids for managing tuberculous meningitis. Cochrane Database Syst Rev. 2016;4:CD002244. doi:10.1002/14651858.CD002244.pub4.
   PubMedGoogle Scholar
• Donald PR, Schoeman JF. Tuberculous meningitis. N Engl J Med. 2004;351(17):1719–1720. doi:10.1056/NEJMp048227.
   PubMed Web of Science ®Google Scholar
• Abo YN, Curtis N, Butters C, et al. Successful Treatment of a Severe Vision-Threatening Paradoxical Tuberculous Reaction with Infliximab: First Pediatric Use. Pediatr Infect Dis J. 2020;39(4):e42–e45. doi:10.1097/INF.0000000000002578.
   PubMed Web of Science ®Google Scholar
• Thampi N, Stephens D, Rea E, Kitai I. Unexplained deterioration during antituberculous therapy in children and adolescents: clinical presentation and risk factors. Pediatr Infect Dis J. 2012;31(2):129–133. doi:10.1097/INF.0b013e318239134c.
   PubMed Web of Science ®Google Scholar
• Gray K, Wood N, Gunasekera H, et al. Vitamin d and tuberculosis status in refugee children. Pediatr Infect Dis J. 2012;31(5):521–523. doi:10.1097/INF.0b013e3182456c55.
   PubMed Web of Science ®Google Scholar
• Wejse C, Gomes VF, Rabna P, et al. Vitamin D as supplementary treatment for tuberculosis: a double-blind, randomized, placebo-controlled trial. Am J Respir Crit Care Med. 2009;179(9):843–850. doi:10.1164/rccm.200804-567OC.
   PubMed Web of Science ®Google Scholar
• Sinclair D, Abba K, Grobler L, Sudarsanam TD. Nutritional supplements for people being treated for active tuberculosis. Cochrane Database Syst Rev. 2011;(11):CD006086. doi:10.1002/14651858.CD006086.pub3.
   Web of Science ®Google Scholar
• Ganmaa D, Uyanga B, Zhou X, et al. Vitamin D Supplements for Prevention of Tuberculosis Infection and Disease. N Engl J Med. 2020;383(4):359–368. doi:10.1056/NEJMoa1915176.
   PubMed Web of Science ®Google Scholar
• Jolliffe DA, Ganmaa D, Wejse C, et al. Adjunctive vitamin D in tuberculosis treatment: meta-analysis of individual participant data. Eur Respir J. 2019;53(3):1802003. doi:10.1183/13993003.02003-2018.
   Web of Science ®Google Scholar
• Elias AF, Dunn J, Huntington MK. Tuberculosis and profound hypovitaminosis D in an infant. Pediatr Infect Dis J. 2011;30(11):1008–1010. doi:10.1097/INF.0b013e3182271947.
   PubMed Web of Science ®Google Scholar
• Battersby AJ, Kampmann B, Burl S. Vitamin D in early childhood and the effect on immunity to Mycobacterium tuberculosis. Clin Dev Immunol. 2012;2012:430972 doi:10.1155/2012/430972.
   PubMed Web of Science ®Google Scholar
• Godel J, Canadian Paediatric Society Vitamin D supplementation: Recommendations for Canadian mothers and infants. Paediatr Child Health. 2007;12(7):583–589. doi:10.1093/pch/12.7.583.
   PubMed Web of Science ®Google Scholar
• Panel on Antiretroviral Therapy and Medical Management of Children Living with HIV. Guidelines for the Use of Antiretroviral Agents in Pediatric HIV Infection. Available at: https://clinicalinfo.hiv.gov/en/guidelines/pediatric-arv/whats-new-guidelines. Accessed August 10, 2021.
   Google Scholar
• World HealthOrganization. Consolidated Guidelines on the Use of Antiretroviral Drugs for Treating and Preventing HIV Infection:recommendations for a Public Health Approach. 2nd ed. Geneva: WHO Press; 2016. Available at: https://apps.who.int/iris/handle/10665/208825. Accessed August 10, 2021.
   Google Scholar
• Jacobs TG, Svensson EM, Musiime V, the WHO Paediatric Antiretroviral Working Group, et al. Pharmacokinetics of antiretroviral and tuberculosis drugs in children with HIV/TB co-infection: a systematic review. J Antimicrob Chemother. 2020;75(12):3433–3457. doi:10.1093/jac/dkaa328.
   PubMed Web of Science ®Google Scholar
• Getahun H, Chaisson RE, Raviglione M. Latent Mycobacterium tuberculosis Infection. N Engl J Med. 2015;373(12):1179–1180. doi:10.1056/NEJMc1508223.
   PubMedGoogle Scholar
• Kitai I, Morris SK, Kordy F, Lam R. Diagnosis and management of pediatric tuberculosis in Canada. CMAJ. 2017;189(1):E11–E16. doi:10.1503/cmaj.151212.
   PubMed Web of Science ®Google Scholar
• Laurenti P, Raponi M, de Waure C, et al. Performance of interferon-γ release assays in the diagnosis of confirmed active tuberculosis in immunocompetent children: a new systematic review and meta-analysis. BMC Infect Dis. 2016;16:131 doi:10.1186/s12879-016-1461-y.
   PubMed Web of Science ®Google Scholar
• Kay AW, Islam SM, Wendorf K, et al. Interferon-γ Release Assay Performance for Tuberculosis in Childhood. Pediatrics. 2018;141(6):e20173918. doi:10.1542/peds.2017-3918.
   Web of Science ®Google Scholar
• Taylor Z, Nolan CM, Blumberg HM. Controlling tuberculosis in the United States. Recommendations from the American Thoracic Society, CDC, and the Infectious Diseases Society of America. MMWR Recomm Rep. 2005;54(RR-12):1–81. Erratum in MMWR Morb Mortal Wkly Rep. 2005;54(45):1161.
   PubMedGoogle Scholar
• Ho CS, Feng PI, Narita M, Stout JE, Chen M, Pascopella L, Garfein R, Reves R, Katz DJ; Tuberculosis Epidemiologic Studies Consortium. Comparison of three tests for latent tuberculosis infection in high-risk people in the USA: an observational cohort study. Lancet Infect Dis. 2022;22(1):85–96. doi:10.1016/S1473-3099(21)00145-6.
   PubMed Web of Science ®Google Scholar
• Ahmed A, Feng PI, Gaensbauer JT, Reves RR, Khurana R, Salcedo K, Punnoose R, Katz DJ, for the TUBERCULOSIS EPIDEMIOLOGIC STUDIES CONSORTIUM. Interferon-γ Release Assays in Children <15 Years of Age. Pediatrics. 2022;145(1):e20191930. doi:10.1542/peds.2020-0467.
   Google Scholar
• Wendorf KA, Lowenthal P, Feraud J, Cabanting N, Murto C; Interferon-γ Release Assays for Tuberculosis Infection Diagnosis in Refugees <5 Years Old. Pediatrics. 2020;146(4):e20200715. doi:10.1542/peds.2020-0715.
   PubMed Web of Science ®Google Scholar
• Lombardi G, Pellegrino MT, Denicolò A, Corsini I, Tadolini M, Bergamini BM, Meacci M, Garazzino S, Peracchi M, Lanari M, Re MC, Dal Monte P. QuantiFERON-TB Performs Better in Children, Including Infants, than in Adults with Active Tuberculosis: a Multicenter Study. J Clin Microbiol. 2019;57(10):e01048–19. doi:10.1128/JCM.01048-19.
   PubMed Web of Science ®Google Scholar
• Pediatric Tuberculosis Collaborative Group. Targeted Tuberculin Skin Testing and Treatment of Latent Tuberculosis Infection in Children and Adolescents. Pediatrics. 2004;114(Supplement 4):1175–1201. doi:10.1542/peds.2004-0809.
   Web of Science ®Google Scholar
• Yasseen AS, Rea E, Hirji MM, et al. Paediatric tuberculosis among the foreign-born: utility of the Canadian TB immigration medical surveillance programme. Int J Tuberc Lung Dis. 2019;23(1):105–111. doi:10.5588/ijtld.18.0317.
   PubMed Web of Science ®Google Scholar
• Islam S. Interferon-γ-Release-Assay Results in Asymptomatic Children-Further Evidence That Testing for Tuberculosis Should Be More Selective. J Pediatric Infect Dis Soc. 2015;4(4):393–394. doi:10.1093/jpids/piv054.
   PubMed Web of Science ®Google Scholar
• Villarino ME, Scott NA, Weis SE, Tuberculosis Trials Consortium, et al. Treatment for Preventing Tuberculosis in Children and adolescents: a randomized clinical trial of a 3-month, 12-dose regimen of a combination of rifapentine and isoniazid. JAMA Pediatr. 2015;169(3):247–247. doi:10.1001/jamapediatrics.2014.3158.
   PubMed Web of Science ®Google Scholar
• Yang H, Yang Y, Hu ZD, et al. High rate of completion for weekly rifapentine plus isoniazid treatment in Chinese children with latent tuberculosis infection-A single center study. PLoS One. 2021;16(6):e0253159. doi:10.1371/journal.pone.0253159.
   Web of Science ®Google Scholar
• Diallo T, Adjobimey M, Ruslami R, et al. Safety and Side Effects of Rifampin versus Isoniazid in Children. N Engl J Med. 2018;379(5):454–463. doi:10.1056/NEJMoa1714284.
   PubMed Web of Science ®Google Scholar
• Cruz AT, Starke JR. Safety and Adherence for 12 Weekly Doses of Isoniazid and Rifapentine for Pediatric Tuberculosis Infection. Pediatr Infect Dis J. 2016;35(7):811–813. doi:10.1097/INF.0000000000001164.
   PubMed Web of Science ®Google Scholar
• Gaensbauer J, Aiona K, Haas M, et al. Better Completion of Pediatric Latent Tuberculosis Treatment Using 4 Months of Rifampin in a US-based Tuberculosis Clinic. Pediatr Infect Dis J. 2018;37(3):224–228. doi:10.1097/INF.0000000000001721.
   PubMed Web of Science ®Google Scholar
• Akolo C, Adetifa I, Shepperd S, Volmink J. Treatment of latent tuberculosis infection in HIV infected persons. Cochrane Database Syst Rev. 2010;(1):CD000171. doi:10.1002/14651858.CD000171.pub3.
   PubMed Web of Science ®Google Scholar
• Panel on Opportunistic Infections in HIV-Exposed and HIV-Infected Children. Guidelines for the Prevention and Treatment of Opportunistic Infections in HIV-Exposed and HIV-Infected Children. Department of Health and Human Services. Available at: https://clinicalinfo.hiv.gov/en/guidelines/pediatric-opportunistic-infection/mycobacterium-tuberculosis?view=full. Accessed August 10, 2021.
   Google Scholar
• Panel on Guidelines for the Prevention and Treatment of Opportunistic Infections in Adults and Adolescents with HIV. Guidelines for the Prevention and Treatment of Opportunistic Infections in HIV-infected Adults and Adolescents: Recommendations from the Centers for Disease Control and Prevention, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America. Available at: https://clinicalinfo.hiv.gov/en/guidelines/adult-and-adolescent-opportunistic-infection/whats-new-guidelines. Accessed August 10, 2021.
   Google Scholar
• Migliori GB, Tiberi S, Zumla A, members of the Global Tuberculosis Network, et al. MDR/XDR-TB management of patients and contacts: Challenges facing the new decade. The 2020 clinical update by the Global Tuberculosis Network. Int J Infect Dis. 2020;92S:S15–S25. doi:10.1016/j.ijid.2020.01.042.
   PubMedGoogle Scholar
• World Health Organization. Latent Tuberculosis Infection: updated and Consolidated Guidelines for Programmatic Management. Geneva: WHO Press; 2018.
   Google Scholar
• Lee SW, Oh DK, Lee SH, et al. Time interval to conversion of interferon-gamma release assay after exposure to tuberculosis. Eur Respir J. 2011;37(6):1447–1452. doi:10.1183/09031936.00089510.
   Web of Science ®Google Scholar
• Wootton SH, Gonzalez BE, Pawlak R, et al. Epidemiology of pediatric tuberculosis using traditional and molecular techniques: Houston, Texas. Pediatrics. 2005;116(5):1141–1147. doi:10.1542/peds.2004-2701.
   PubMed Web of Science ®Google Scholar
• Muñoz FM, Ong LT, Seavy D, et al. Tuberculosis among adult visitors of children with suspected tuberculosis and employees at a children’s hospital. Infect Control Hosp Epidemiol. 2002;23(10):568–572. doi:10.1086/501972.
   PubMed Web of Science ®Google Scholar
• Jana N, Vasishta K, Jindal SK, et al. Perinatal outcome in pregnancies complicated by pulmonary tuberculosis. Int J Gynaecol Obstet. 1994;44(2):119–124. doi:10.1016/0020-7292(94)90064-7.
   PubMed Web of Science ®Google Scholar
• Peng W, Yang J, Liu E. Analysis of 170 cases of congenital TB reported in the literature between 1946 and 2009. Pediatr Pulmonol. 2011;46(12):1215–1224. doi:10.1002/ppul.21490.
   PubMed Web of Science ®Google Scholar
• Adhikari M, Pillay T, Pillay DG. Tuberculosis in the newborn: an emerging disease. Pediatr Infect Dis J. 1997;16(12):1108–1112. doi:10.1097/00006454-199712000-00003.
   PubMed Web of Science ®Google Scholar
• Asuquo B, Vellore AD, Walters G, et al. A case-control study of the risk of adverse perinatal outcomes due to tuberculosis during pregnancy. J Obstet Gynaecol. 2012;32(7):635–638. doi:10.3109/01443615.2012.704436.
   Google Scholar
• Figueroa-Damian R, Arredondo-Garcia JL. Neonatal outcome of children born to women with tuberculosis. Arch Med Res. 2001;32(1):66–69. doi:10.1016/s0188-4409(00)00266-6.
   PubMed Web of Science ®Google Scholar
• LaCourse SM, Greene SA, Dawson-Hahn EE, Hawes SE. Risk of Adverse Infant Outcomes Associated with Maternal Tuberculosis in a Low Burden Setting: A Population-Based Retrospective Cohort Study. Infect Dis Obstet Gynecol. 2016;2016:1–8. doi:10.1155/2016/6413713.
   Google Scholar
• Li Q, Song Y, Chen H, et al. Retrospective Analysis of 28 Cases of Tuberculosis in Pregnant Women in China. Sci Rep. 2019;9(1):15347. doi:10.1038/s41598-019-51695-8.
   PubMedGoogle Scholar
• Chopra S, Siwatch S, Aggarwal N, et al. Pregnancy outcomes in women with tuberculosis: a 10-year experience from an Indian tertiary care hospital. Trop Doct. 2017;47(2):104–109. doi:10.1177/0049475516665765.
   PubMed Web of Science ®Google Scholar
• Sobhy S, Babiker Z, Zamora J, et al. Maternal and perinatal mortality and morbidity associated with tuberculosis during pregnancy and the postpartum period: a systematic review and meta-analysis. BJOG. 2017;124(5):727–733. doi:10.1111/1471-0528.14408.
   PubMed Web of Science ®Google Scholar
• Hageman J, Shulman S, Schreiber M, et al. Congenital tuberculosis: critical reappraisal of clinical findings and diagnostic procedures. Pediatrics. 1980;66(6):980–984.
   Web of Science ®Google Scholar
• Cantwell MF, Shehab ZM, Costello AM, et al. Brief report: congenital tuberculosis. N Engl J Med. 1994;330(15):1051–1054. doi:10.1056/NEJM199404143301505.
   PubMed Web of Science ®Google Scholar
• World HealthOrganization. Guidance for National Tuberculosis Programmes on the Management of Tuberculosis in Children. 2nd ed. Geneva: WHO Press; 2014.
   Google Scholar
• Government of Victoria. Management, Control and Prevention of Tuberculosis: Guidelines for Health Care Providers. Available at: https://content.health.vic.gov.au/sites/default/files/migrated/files/collections/policies-and-guidelines/t/tb-guidelines-2015.pdf. 2015. Accessed on August 10, 2021.
   Google Scholar
• Behr MA, Wilson MA, Gill WP, et al. Comparative genomics of BCG vaccines by whole-genome DNA microarray. Science. 1999;284(5419):1520–1523. doi:10.1126/science.284.5419.1520.
   PubMed Web of Science ®Google Scholar
• World Health Organization. WHO vaccine preventable diseases monitoring system: 2003 global summary. World Health Organization. 2003. Available at: https://apps.who.int/iris/handle/10665/68469. Accessed August 10, 2021.
   Google Scholar
• Wherrett G. The Miracle of the Empty Beds: A History of Tuberculosis in Canada. Toronto: University of Toronto Press. 1977.
   Google Scholar
• Hopkins J. BCG vaccination in Montreal. Am Rev Tuberc. 1941;43:581–599.
   Google Scholar
• Ferguson R, Simes A. BCG vaccination of Indian infants in Saskatchewan. Tubercle. 1949;30(1):5–11. doi:10.1016/S0041-3879(49)80055-9.
   PubMedGoogle Scholar
• World Health Organization. Bacillus Calmette–Guérin (BCG) vaccination coverage. Available at: https://immunizationdata.who.int/pages/coverage/bcg.html?CODE=Global&YEAR=. Accessed August 10, 2021.
   Google Scholar
• Zwerling A, Behr MA, Verma A, et al. The BCG World Atlas: a database of global BCG vaccination policies and practices. PLoS Med. 2011;8(3):e1001012. doi:10.1371/journal.pmed.1001012.
   PubMed Web of Science ®Google Scholar
• Faust L, Schreiber Y, Bocking N. A systematic review of BCG vaccination policies among high-risk groups in low TB-burden countries: implications for vaccination strategy in Canadian indigenous communities. BMC Public Health. 2019;19(1):1504 doi:10.1186/s12889-019-7868-9.
   PubMed Web of Science ®Google Scholar
• Dehghani K, Lan Z, Li P, et al. Determinants of tuberculosis trends in six Indigenous populations of the USA, Canada, and Greenland from 1960 to 2014: a population-based study. Lancet Public Health. 2018;3(3):e133–e142. doi:10.1016/S2468-2667(18)30002-1.
   PubMed Web of Science ®Google Scholar
• Government of Canada. Tuberculosis: Symptoms and treatment. 2019. Available at: https://www.canada.ca/en/public-health/services/diseases/tuberculosis.html. Accessed August 8, 2021.
   Google Scholar
• Roy A, Eisenhut M, Harris RJ, et al. Effect of BCG vaccination against Mycobacterium tuberculosis infection in children: systematic review and meta-analysis. BMJ. 2014;349:g4643. doi:10.1136/bmj.g4643.
   PubMed Web of Science ®Google Scholar
• Mangtani P, Abubakar I, Ariti C, et al. Protection by BCG vaccine against tuberculosis: a systematic review of randomized controlled trials. Clin Infect Dis. 2014;58(4):470–480. doi:10.1093/cid/cit790.
   PubMed Web of Science ®Google Scholar
• Abubakar I, Pimpin L, Ariti C, et al. Systematic review and meta-analysis of the current evidence on the duration of protection by bacillus Calmette-Guérin vaccination against tuberculosis. Health Technol Assess. 2013;17(37):1–372. v-vi. doi:10.3310/hta17370.
   PubMed Web of Science ®Google Scholar
• World Health Organization. Evidence to recommendation table: Need for revaccination. 2017. Available at: https://www.who.int/immunization/policy/position_papers/bcg_evidence_recommendation_table_revaccination.pdf. Accessed August 10, 2021.
   Google Scholar
• World Health Organization. BCG vaccine: WHO position paper, February 2018 - Recommendations. Vaccine. 2018;36(24):3408–3410. doi:10.1016/j.vaccine.2018.03.009.
   PubMed Web of Science ®Google Scholar
• Comstock GW. Does the protective effect of neonatal BCG vaccination correlate with vaccine-induced tuberculin reactions? Am J Respir Crit Care Med. 1996;154(1):263–264. doi:10.1164/ajrccm.154.1.8680692.
   Google Scholar
• Al-Kassimi FA, Al-Hajjaj MS, Al-Orainey IO, Bamgboye EA. Does the protective effect of neonatal BCG correlate with vaccine-induced tuberculin reaction? Am J Respir Crit Care Med. 1995;152(5 Pt 1):1575–1578. doi:10.1164/ajrccm.152.5.7582297.
   PubMed Web of Science ®Google Scholar
• Government of Canada. Bacille Calmette-Guérin (BCG) vaccine: Canadian Immunization Guide. 2014. Available at: https://www.canada.ca/en/public-health/services/publications/healthy-living/canadian-immunization-guide-part-4-active-vaccines/page-2-bacille-calmette-guerin-vaccine.html. Accessed August 10, 2021.
   Google Scholar
• Badurdeen S, Marshall A, Daish H, et al. Safety and Immunogenicity of Early Bacillus Calmette-Guérin Vaccination in Infants Who Are Preterm and/or Have Low Birth Weights: A Systematic Review and Meta-analysis. JAMA Pediatr. 2019;173(1):75–85. doi:10.1001/jamapediatrics.2018.4038.
   PubMed Web of Science ®Google Scholar
• Venkataraman A, Yusuff M, Liebeschuetz S, et al. Management and outcome of Bacille Calmette-Guérin vaccine adverse reactions. Vaccine. 2015;33(41):5470–5474. doi:10.1016/j.vaccine.2015.07.103.
   Web of Science ®Google Scholar
• Cuello-Garcia CA, Perez-Gaxiola G, Jimenez Gutierrez C, Cochrane Infectious Diseases Group Treating BCG-induced disease in children. Cochrane Database Syst Rev. 2013;(1):CD008300. doi:10.1002/14651858.CD008300.pub2.
   Web of Science ®Google Scholar
• Khan S, Stimec J, Kitai I. Nonresponding osteomyelitis in a two-year-old boy. CMAJ. 2015;187(12):901–904. doi:10.1503/cmaj.140989.
   PubMed Web of Science ®Google Scholar
• Deeks SL, Clark M, Scheifele DW, et al. Serious adverse events associated with bacille Calmette-Guérin vaccine in Canada. Pediatr Infect Dis J. 2005;24(6):538–541. doi:10.1097/01.inf.0000164769.22033.2c.
   PubMed Web of Science ®Google Scholar
• Ong RYL, Chan SB, Chew SJ, et al. Disseminated BACILLUS-CALMETTE-GUÉRIN INFECTIONS AND PRIMARY IMMUNODEFICIENCY DISORDERS IN SINGAPORE: A SINGLE CENTER 15-YEAR RETROSPECTIVE REVIEW. Int J Infect Dis. 2020;97:117–125. doi:10.1016/j.ijid.2020.05.117.
   PubMed Web of Science ®Google Scholar
• Azzopardi P, Bennett CM, Graham SM, Duke T. Bacille Calmette-Guerin vaccine-related disease in HIV-infected children: a systematic review. Int J Tuberc Lung Dis. 2009;13(11):1331–1344.
   PubMed Web of Science ®Google Scholar
• Bernatowska E, Skomska-Pawliszak M, Wolska-Kuśnierz B, et al. BCG Moreau Vaccine Safety Profile and NK Cells-Double Protection Against Disseminated BCG Infection in Retrospective Study of BCG Vaccination in 52 Polish Children with Severe Combined Immunodeficiency. J Clin Immunol. 2020;40(1):138–146. doi:10.1007/s10875-019-00709-1.
   PubMed Web of Science ®Google Scholar
• Marciano BE, Huang CY, Joshi G, et al. BCG vaccination in patients with severe combined immunodeficiency: complications, risks, and vaccination policies. J Allergy Clin Immunol. 2014;133(4):1134–1141. doi:10.1016/j.jaci.2014.02.028.
   PubMed Web of Science ®Google Scholar
• Rozmus J, Junker A, Thibodeau ML, et al. Severe combined immunodeficiency (SCID) in Canadian children: a national surveillance study. J Clin Immunol. 2013;33(8):1310–1316. doi:10.1007/s10875-013-9952-8.
   PubMed Web of Science ®Google Scholar
• Du Preez K, Seddon JA, Schaaf HS, et al. Global shortages of BCG vaccine and tuberculous meningitis in children. Lancet Glob Health. 2019;7(1):e28–e29. doi:10.1016/S2214-109X(18)30474-1.
   PubMed Web of Science ®Google Scholar
• Harris RC, Dodd PJ, White RG. The potential impact of BCG vaccine supply shortages on global paediatric tuberculosis mortality. BMC Med. 2016;14(1):138. doi:10.1186/s12916-016-0685-4.
   PubMedGoogle Scholar
• National Advisory Committee on Immunization. Statement on Bacille Calmette-Guérin Vaccine, Canadian Communicable Disease Report. Vol. 30. ACS-5; Public Health Agency of Canada; 2004. http://www.phac-aspc.gc.ca/publicat/ccdr-rmtc.
   Google Scholar
• International Union Against Tuberculosis and Lung Disease. Criteria for discontinuation of vaccination programmes using Bacille Calmette-Guerin (BCG) in countries with a low prevalence of tuberculosis. Tuber Lung Dis. 1994;75(3):179–180. doi:10.1016/0962-8479(94)90003-5.
   PubMedGoogle Scholar
• FIND The Global Alliance for Diagnostics. Sample collection: Inducing Sputum Training Video. 2019. Available at: https://www.youtube.com/watch?v=0LPkpY4KIkU.Accessed. Accessed September 7, 2021.
   Google Scholar
• Montreal Public Health. The Practical Guide to Applying DOT. 2013.
   Google Scholar